Sai Prabhakar
@PrabhakRegrefre
Followers
73
Following
57
Media
0
Statuses
35
ML @AnteriorAI | CMU, IIT Madras | #1 at Abridge AI AI Researcher Community Advisor @NskAiCommunity
USA
Joined May 2014
AI Eats Bio: 1/5 @RecursionPharma combines automated wet-lab biology + AI to industrialize drug discovery. They run millions of cell experiments, use AI to decode them, and identify treatments. Biz model: In-house drug development and partnerships with #BigPharma
1
0
1
So much great stuff covered this week, but the sessions on AI's implication in healthcare and pharma were definitely my favorite. @Ifeanyiokala, @PrabhakRegrefre, Chukwuebuka (Ebuka), the whole @NskAiCommunity you've made a lasting impact on my career. THANK YOU!
Week 5 Recap – #nskaiBootcamp This week we explored: -Advanced RAG (self-reflective & adaptive) -Model Merging in LLMs -Beyond fidelity; Synthetic Clinical Data -A key note speech, from a senior ML engineer @Apple One week left! Let’s finish strong 💡 #nskai #nskaicommunity
0
1
1
🎉 Launched my Medical RAG Assistant for EFDA Guidelines! 🚀 This AI-powered app uses LangChain, Groq, & Streamlit to answer queries on medicine regs, imports, & exports from EFDA docs. 🔗 https://t.co/DXoVyXMj2Z 📂 https://t.co/hUt7icsO30
@PrabhakRegrefre @NskAiCommunity
1
3
7
Another useful project from our @NskAiCommunity free boot camp. Excited to see what ppl are going to deliver for the hackathon next.
🎉 Launched my Medical RAG Assistant for EFDA Guidelines! 🚀 This AI-powered app uses LangChain, Groq, & Streamlit to answer queries on medicine regs, imports, & exports from EFDA docs. 🔗 https://t.co/DXoVyXMj2Z 📂 https://t.co/hUt7icsO30
@PrabhakRegrefre @NskAiCommunity
0
0
1
And I could study a50pages pdf within 3 hours having every question answered and understood in much simpler way ❤️😊 Much thanks to our tutors and mentors from @NskAiCommunity we are very grateful to you Ifeanyi @PrabhakRegrefre and the others
1
3
6
Another project from our bootcamp with @NskAiCommunity!!!
Huge thanks to the https://t.co/LQRy3Rqhod team—especially Chukwuebuka Chukwudi, Ifeanyi Okala, and Sai Prabhakar—for their mentorship! 👉 Live Demo: Project1 RAG Demo hashtag#RAG hashtag#Llama3 hashtag#LangChain hashtag#HuggingFace hashtag#VectorSearch hashtag#AI hashtag#NSKAI
0
1
6
I am continually amazed by the participants' willingness to learn about AI outside their job. Our free AI boot camp with @NskAiCommunity is in its final stages. Going strong thanks to @Ifeanyiokala @EbukaChuqz !!!
🔎 Imagine uploading a book, asking it a question… and the book whispers back the answer. That’s what I built as my first project at https://t.co/aB1RPariRl Bootcamp: a naive RAG 🤓 👉 Try it live: https://t.co/zPiIm4hpXA
@NskAiCommunity @PrabhakRegrefre
1
3
8
Huge thanks to the https://t.co/LQRy3Rqhod team—especially Chukwuebuka Chukwudi, Ifeanyi Okala, and Sai Prabhakar—for their mentorship! 👉 Live Demo: Project1 RAG Demo hashtag#RAG hashtag#Llama3 hashtag#LangChain hashtag#HuggingFace hashtag#VectorSearch hashtag#AI hashtag#NSKAI
0
3
8
5/5 Can they win? Early signs are promising, but need real-world proof and more Phase 2. Investor caution: biotech funding down 20% in Q1, 62% of VC rounds now go to clinical-stage companies. If @RecursionPharma gets drugs to patients → they define the Bio+AI era.
0
0
0
4/5 What could 2025–26 look like? - Phase 2+ progress for REC-4881 & REC-7735 - New platform (Boltz-2) boosts prediction speed - More milestone cash from partners - REV102 (rare bone disease) heads toward the clinic This is Recursion's make-or-break window.
1
0
0
3/5 2025 strategy: - Cuts: 3 programs, paused 1 preclinical, laid off 20% - Refocused pipeline → from broad early-stage bets to a few high-confidence programs in rare disease & oncology - Depth > breadth: REC-4881 (FAP), REC-7735 (PI3K+ BC), REV-102 (bone)
1
0
0
2/5 What have they achieved? Hit multiple $ milestones with @sanofi - Early clinical signal for REC-4881 (rare disease): 43% median reduction in polyp burden - Preclinical success for REC-7735 (targeted breast cancer).
1
0
0
🎉🚀 Exciting Milestone Alert! 🚀🎉 I'm thrilled to share this milestone with you all! From being the first employee to witnessing the journey from 0 to $850 Million since the company's inception, the ride was filled with learning, hard work, and innovation. #genai #healthai
📣 Today, we are announcing our $150M Series C! This is one of the largest funding rounds made to date in generative AI for healthcare. We are grateful to the luminary investors and iconic institutions who believe in us and our mission—to power deeper understanding in
0
0
2
In the @nytimes, read how @AbridgeHQ with our users at @UPMC, @KUMedCenter, and independent physicians across the U.S. is giving doctors their evenings back with a solution that uses evidence-backed generative AI to automate note-taking:
nytimes.com
The best use for generative A.I. in health care, doctors say, is to ease the heavy burden of documentation that takes them hours a day and contributes to burnout.
0
6
16
We are looking for amazing MLOps engineers, come join us!!
Do you live at the intersection of engineering, ops, & ML/NLP? Are you excited to engineer robust infrastructure for building, testing, & deploying robust ML systems w many moving parts? Join us at @AbridgeHQ & help build the future of ML in healthcare
0
0
4
Super stoked to start working more closely with @zacharylipton!!!
Exciting news! Thrilled to welcome @zacharylipton as our first Chief Scientific Officer. As a pioneer in the application of modern machine-learning techniques to healthcare data, Zachary's expertise will help improve the provider-patient experience. https://t.co/Iw7L12ZeAV
#ai
0
0
3
Abridge is on the list of the top 150 most promising digital health companies! Thanks to the team’s amazing work in helping clinicians and patients go with cutting-edge ambient AI and conversation understanding!#AI #healthcare #NLP #GenerativeAI
https://t.co/KEgbDFTQDZ
businesswire.com
CB Insights today named Abridge, the leader in medical conversation AI, to its fourth-annual Digital Health 150, showcasing the 150 most promising private di...
0
0
3
Thrilled to be recommended in today's @nytimes! "An app called Abridge records doctor-patient conversations and shares the recording and transcript with the patient while also summarizing the information for the physician to help with record keeping."
Terrific piece by @lindy2350 @nytimes...'Facing Surgery? Here’s How to Prepare. The best way to navigate a surgery recommendation is to ask a lot of questions.' https://t.co/50yw7FXGd7
@YaleMed @AbridgeHQ @glynelwyn
0
4
13
Finally, I can share about our medical conversation understanding work and our latest funding round which includes Turing Award winner Yoshua Bengio! We are looking for super smart NLP researchers to join our amazing team! #healthcare #NLP #conversationalAI #Hiring
Thrilled to announce our $12.5M Series A-1 and the launch of Abridge for Enterprises — the only AI-first service that transforms conversations into medical documentation for providers and patients alike. Learn more: https://t.co/0BrghauAO6
#ai #healthtech #MachineLearning
1
0
5
✍️Thrilled to share via @qz the notes I took over years: observing @IBMWatsonHealth's trajectory from the outside, understanding healthcare incentives from the inside at @UPMC and more importantly, breathing/building AI+Health every day at @AbridgeHQ
Where did IBM go wrong with Watson Health?
2
7
15